Additionally, miR-103a-3p suppresses cell proliferation and invasion by targeting tumor protein D52 in prostate cancer [18] but promotes human gastric cancer cell proliferation by targeting activating transcription factor 7 (ATF7) [19], and it also promotes tumor growth and glycolysis through the Hippo pathway in colorectal cancer [20]. Here, TPD52 is linked to gastric cancer.